company background image
XRAY logo

DENTSPLY SIRONA NasdaqGS:XRAY Rapporto sulle azioni

Ultimo prezzo

US$18.52

Cap. di mercato

US$3.8b

7D

6.7%

1Y

-40.9%

Aggiornato

20 Nov, 2024

Dati

Dati finanziari dell'azienda +

DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Rapporto sulle azioni

Cap. di mercato: US$3.8b

XRAY Panoramica delle azioni

DENTSPLY SIRONA Inc. produce e vende vari prodotti e tecnologie dentali in tutto il mondo. Maggiori dettagli

XRAY analisi fondamentale
Punteggio fiocco di neve
Valutazione5/6
Crescita futura3/6
Prestazioni passate0/6
Salute finanziaria3/6
Dividendi4/6

DENTSPLY SIRONA Inc. Concorrenti

Storia dei prezzi e prestazioni

Riepilogo dei massimi storici, delle variazioni e dei cali di prezzo di tutti i tempi per DENTSPLY SIRONA
Prezzi storici delle azioni
Prezzo attuale dell'azioneUS$18.52
Massimo di 52 settimaneUS$37.60
Minimo di 52 settimaneUS$17.21
Beta1.03
1Variazione di 1 mese-24.19%
Variazione a 3 mesi-23.28%
Variazione di 1 anno-40.94%
3Variazione a 3 anni-63.87%
Variazione a 5 anni-67.57%
Variazione dall'IPO2,553.61%

Notizie e aggiornamenti recenti

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Recent updates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Rendimenti per gli azionisti

XRAYUS Medical EquipmentUS Mercato
7D6.7%-0.4%-1.0%
1Y-40.9%20.3%30.3%

Ritorno vs Industria: XRAY ha avuto una performance inferiore rispetto al US Medical Equipment che ha registrato un rendimento 20.3 % nell'ultimo anno.

Rendimento vs Mercato: XRAY ha avuto una performance inferiore al mercato US che ha registrato un rendimento 30.3 % nell'ultimo anno.

Volatilità dei prezzi

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement8.9%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Prezzo delle azioni stabile: XRAY non ha avuto una volatilità dei prezzi significativa negli ultimi 3 mesi.

Volatilità nel tempo: La volatilità settimanale ( 9% ) di XRAY è rimasta stabile nell'ultimo anno.

Informazioni sull'azienda

FondatoI dipendentiAMMINISTRATORE DELEGATOSito web
187715,000Simon Campionwww.dentsplysirona.com

DENTSPLY SIRONA Inc. produce e vende vari prodotti e tecnologie dentali in tutto il mondo. Opera in quattro segmenti: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions e Wellspect Healthcare. L'azienda offre attrezzature dentali che comprendono apparecchiature di imaging, manipoli dentali motorizzati, centri di trattamento, altri strumenti, amalgamatori, miscelatori e forni per porcellana; e tecnologie dentali CAD/CAM per supportare i restauri dentali, come scanner intraorali, stampanti 3D, frese, altri software e servizi e un restauro economico full-chairside di odontoiatria estetica in ceramica, oltre a DS Core, la sua piattaforma basata su cloud.

DENTSPLY SIRONA Inc. Riepilogo dei fondamenti

Come si confrontano gli utili e i ricavi di DENTSPLY SIRONA con la sua capitalizzazione di mercato?
XRAY statistiche fondamentali
Capitalizzazione di mercatoUS$3.75b
Guadagni(TTM)-US$413.00m
Ricavi(TTM)US$3.90b

0.9x

Rapporto P/S

-8.9x

Rapporto P/E

Guadagni e ricavi

Statistiche chiave sulla redditività dall'ultima relazione sugli utili (TTM)
XRAY Conto economico (TTM)
RicaviUS$3.90b
Costo del fatturatoUS$1.87b
Profitto lordoUS$2.04b
Altre speseUS$2.45b
Guadagni-US$413.00m

Ultimi guadagni dichiarati

Sep 30, 2024

Prossima data di guadagno

n/a

Utile per azione (EPS)-2.08
Margine lordo52.18%
Margine di profitto netto-10.59%
Rapporto debito/patrimonio netto89.7%

Come si è comportato XRAY nel lungo periodo?

Vedi performance storica e confronto

Dividendi

3.5%

Rendimento attuale del dividendo

-31%

Rapporto di remunerazione